Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2019

14.05.2019 | Original Research

Clinical Significance of Serum Vascular Endothelial Growth Factor, Pigment Epithelium–Derived Factor, Tumor Necrosis Factor Alpha, and Progranulin Levels in Patients with Gastric Cancer and Gastric Precancerous Lesions

verfasst von: Evrim Kahramanoğlu Aksoy, Muhammet Yener Akpınar, Özlem Doğan, Zeynep Göktaş, Ferdane Pirinççi Sapmaz, Gülçin Güler Şimşek, Metin Uzman, Yaşar Nazlıgül

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The purpose of this study is to evaluate serum levels of vascular endothelial growth factor (VEGF), pigment epithelium–derived factor (PEDF), tumor necrosis factor alpha (TNF-α), and progranulin in patients with gastric cancer (GC) and precancerous lesions (PCL) and to determine the usefulness of these markers as diagnostic biomarkers in these diseases.

Method

A total of 32 GC patients, 35 PCL patients, and 23 healthy controls participated in the study. The serum levels of VEGF, PEDF, TNF-α, and progranulin were measured by enzyme-linked immunosorbent assay (ELISA).

Results

The mean serum VEGF levels were 30.6 ± 12.98 pg/mL in GC, 18.2 ± 5.72 pg/mL in PCL, and 17.5 ± 5.59 pg/mL in controls. GC VEGF levels were significantly higher than both PCL and control groups (p < 0.001). The mean serum PEDF levels were 1516.1 ± 993.8 pg/mL in GC, 1039.1 ± 1002.3 pg/mL in PCL, and 767.5 ± 661.5 pg/mL in controls. The serum PEDF level in the GC group was significantly higher than that in both PCL and control groups (p = 0.004 and p = 0.038, respectively). The mean serum TNF-α levels were 46.7 ± 14.82 pg/mL in GC, 38.4 ± 11.89 pg/mL in PCL, and 33.8 ± 12.77 pg/mL in controls. There was a significant difference between GC and controls (p = 0.022) in TNF-α levels. The mean serum progranulin levels in GC were 2496.6 ± 737.8 pg/mL, 2332.0 ± 482.1 pg/mL in PCL, and 1288.7 ± 830.9 pg/mL in controls. Progranulin levels in both GC and PCL groups were significantly higher than that in the control group (p < 0.001 for both).

Conclusion

There were significant differences among patients with GC and PCL and healthy controls in terms of serum VEGF, PEDF, TNF-α, and progranulin levels.
Literatur
1.
Zurück zum Zitat World Health Organization. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide. 2012, http://globocan.iarc. fr/Pages/fact_sheets_cancer. aspx (accessed June 20, 2016). World Health Organization. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide. 2012, http://​globocan.​iarc. fr/Pages/fact_sheets_cancer. aspx (accessed June 20, 2016).
3.
Zurück zum Zitat Arrington AK. Timing of chemotherapy and survival in patients with resectable gastric adenocarcinoma. World J Gastrointest Surg. 2013;5(12):321–8.CrossRefPubMedPubMedCentral Arrington AK. Timing of chemotherapy and survival in patients with resectable gastric adenocarcinoma. World J Gastrointest Surg. 2013;5(12):321–8.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.PubMed Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.PubMed
6.
Zurück zum Zitat Ding S, Lin S, Dong X, Yang X, Qu H, Huang S, et al. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer. In Vivo. 2005;19:793–5.PubMed Ding S, Lin S, Dong X, Yang X, Qu H, Huang S, et al. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer. In Vivo. 2005;19:793–5.PubMed
7.
Zurück zum Zitat Vidal O, Metges JP, Elizalde I, Valentíni M, Volant A, Molina R, et al. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer. Br J Surg. 2009;96:1443–51.CrossRefPubMed Vidal O, Metges JP, Elizalde I, Valentíni M, Volant A, Molina R, et al. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer. Br J Surg. 2009;96:1443–51.CrossRefPubMed
10.
Zurück zum Zitat Forones NM, Mandowsky SV, Lourenço LG. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Hepatogastroenterology. 2001;48(40):1199–201.PubMed Forones NM, Mandowsky SV, Lourenço LG. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Hepatogastroenterology. 2001;48(40):1199–201.PubMed
12.
Zurück zum Zitat Linē A, Stengrēvics A, Slucka Z, Li G, Jankevics E, Rees RC. Serological identification and expression analysis of gastric cancer-associated genes. Br J Cancer. 2002;86(11):1824–30.CrossRefPubMedPubMedCentral Linē A, Stengrēvics A, Slucka Z, Li G, Jankevics E, Rees RC. Serological identification and expression analysis of gastric cancer-associated genes. Br J Cancer. 2002;86(11):1824–30.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer. 2002;29(2):8.CrossRef Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer. 2002;29(2):8.CrossRef
16.
Zurück zum Zitat Yakut M, Örmeci N, Erdal H, Keskin O, Karayel Z, Tutkak H, et al. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 beta, serum toll-like receptor-4 levels and Helicobacter pylori cag A status. Clin Res Hepatol Gastroenterol. 2013;37(3):302–11. https://doi.org/10.1016/j.clinre.2012.09.013.CrossRefPubMed Yakut M, Örmeci N, Erdal H, Keskin O, Karayel Z, Tutkak H, et al. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 beta, serum toll-like receptor-4 levels and Helicobacter pylori cag A status. Clin Res Hepatol Gastroenterol. 2013;37(3):302–11. https://​doi.​org/​10.​1016/​j.​clinre.​2012.​09.​013.CrossRefPubMed
Metadaten
Titel
Clinical Significance of Serum Vascular Endothelial Growth Factor, Pigment Epithelium–Derived Factor, Tumor Necrosis Factor Alpha, and Progranulin Levels in Patients with Gastric Cancer and Gastric Precancerous Lesions
verfasst von
Evrim Kahramanoğlu Aksoy
Muhammet Yener Akpınar
Özlem Doğan
Zeynep Göktaş
Ferdane Pirinççi Sapmaz
Gülçin Güler Şimşek
Metin Uzman
Yaşar Nazlıgül
Publikationsdatum
14.05.2019
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2019
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00251-8

Weitere Artikel der Ausgabe 3/2019

Journal of Gastrointestinal Cancer 3/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.